Flibanserin and Regulatory Failure

Guest Post by Adriane Fugh-Berman On August 18th, 2015, the FDA approved flibanserin (brand name Addyi), a purported aphrodisiac that can drop blood pressure so precipitously that users sometimes pass out and require medical intervention to regain consciousness.  The labelling for flibanserin indicates that it is for: the treatment of premenopausal women with acquired, generalized hypoactive […]

Read More…

Psychology Is not in Crisis? Depends on What You Mean by “Crisis”

By Brian D. Earp @briandavidearp *Note that this article was originally published at the Huffington Post. Introduction In the New York Times yesterday, psychologist Lisa Feldman Barrett argues that “Psychology Is Not in Crisis.” She is responding to the results of a large-scale initiative called the Reproducibility Project, published in Science magazine, which appeared to […]

Read More…